

2425: The Future of Telemedicine With Ernest Colling
Sep 16, 2024
Ernest Colling, Founder and CEO of Transcend, has a fascinating background that includes military service and intelligence work. He shares his inspiring journey from high school dropout to leading a telemedicine company specializing in peptides. The discussion dives into the game-changing impact of peptide therapies on health, particularly for veterans. Ernest highlights the importance of hormonal balance and preventative medicine while navigating the complexities of the telehealth landscape, emphasizing a more personalized approach to wellness and recovery.
AI Snips
Chapters
Transcript
Episode notes
Colling's Low Testosterone
- Ernest Colling, after serving seven deployments, struggled with low testosterone at 34.
- Doctors dismissed his concerns due to his age, delaying treatment.
Cumulative Injuries
- During his second to last deployment, Colling suffered a back injury that didn't heal properly.
- Subsequent injuries and slow recovery led him to realize the cumulative physical toll of his service.
12-Hour Firefight
- Colling recalls a harrowing 12-hour firefight in Iraq on November 8, 2004.
- His convoy was ambushed, a vehicle destroyed, highlighting the dangers of private contracting.